BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART;VALUE=DATE:20250101
TZNAME:UTC
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Under EMA Policy 70 Publication of Clinical Data\, clinical ove
rviews and study reports submitted as part of a Marketing Authorisation Ap
plication are published and made publically available. \; Before docum
ents are published\, sponsors need to anonymise the documents aligned to d
ata privacy requirements. \; \nThe intent of this webinar is to descri
be what is involved in anonymising clinical data\, and present the differe
nt methods and approaches available for anonymisation including an introdu
ction to residual risk assessment. \; Examples from the PhUSE Data De-
Identification Standard will also be discussed. \nJean-Marc Ferran (Qualia
nce / PhUSE) will present &lsquo\;Anonymising Clinical Data &ndash\; key p
rinciples\, methods and considerations&rsquo\;. \; Chrissie Fletcher w
ill facilitate a Q&\;A session.\nFor details please contact Chrissie Fl
etcher fletcher@amgen.com\nRegistration is now closed.\n\nPlease click her
e \;to view the flyer.\n\nPlease click here \;to view the presenta
tion slides.\n\nTo access the recording\, please visit the Video-on-Demand
Library.
DTEND:20171117T150000Z
DTSTAMP:20260613T025302Z
DTSTART:20171117T140000Z
LOCATION:
SEQUENCE:0
SUMMARY:EFSPI/PSI Webinar: Anonymising Clinical Data
UID:RFCALITEM639169159829132626
X-ALT-DESC;FMTTYPE=text/html:Under EMA Policy 70 Publication of Clin
ical Data\, clinical overviews and study reports submitted as part of
a Marketing Authorisation Application are published and made publically a
vailable. \; Before documents are published\, sponsors need to anonymi
se the documents aligned to data privacy requirements. \;
\nThe
intent of this webinar is to describe what is involved in anonymising cli
nical data\, and present the different methods and approaches available fo
r anonymisation including an introduction to residual risk assessment.&nbs
p\; Examples from the PhUSE Data De-Identification Standard will also be d
iscussed.
\nJean-Marc Ferran (Qualiance / PhUSE) will present &lsqu
o\;Anonymising Clinical Data &ndash\; key principles\, methods and conside
rations&rsquo\;. \; Chrissie Fletcher will facilitate a Q&\;A sessi
on.
\nFor details please contact Chrissie Fletcher fletcher@amgen.com
\nRegistration is now closed.
\n
\nPlease click here \
;to view the flyer.
\n
\nPlease click here \;to view
the presentation slides.
\n
\nTo access the recording\,
please visit the Video-on-Demand Libr
ary.
END:VEVENT
END:VCALENDAR